References
- OECD. Asthma and COPD prevalence. In: Health at a glance: Europe 2012. OECD iLibrary; Organisation for Economic Cooperation and Development (OECD); 2012; [ cited 2015 Jul]. Available from: http://dx.doi.org/10.1787/9789264183896-19-en
- WHO. Chronic obstructive pulmonary disease (COPD). Fact sheet No. 315; [ updated 2015 Jan; cited 2015 July]. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/
- WHO. Global status report on non-communicable diseases 2010. Available from: http://www.who.int/nmh/publications/ncd_report2010/en/
- Aaron SD. Management and prevention of exacerbations of COPD. BMJ. 2014;349:g5237. doi:10.1136/bmj.g5237.
- Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2015; [ cited 2015 Jul]. Available from: http://www.goldcopd.org/
- Cazzola M, Hanania NA, MacNee W, et al. A review of the most common patient-reported outcomes in COPD - revisiting current knowledge and estimating future challenges. Int J COPD. 2015;10:725–738.
- Zysman M, Patout M, Miravitlles M, et al. [COPD and perception of the new GOLD document in Europe. Workshop from the Société de pneumologie de langue française (SPLF)]. Rev Mal Respir. 2014;31:499–510.
- Davis KJ, Landis SH, Oh Y-M, et al. Continuing to confront COPD international physician survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J Chron Obstruct Pulmon Dis. 2014;10:39–55.
- Hurst JR, Vestbo J, Anzueto A, et al. for the ECLIPSE Study Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138.
- Calverley PMA, Anderson JA, Celli B, et al. for the TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–789.
- Tashkin DP, Celli B, Senn S, et al. for the UPLIFT study investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543–1554.
- Perez X, Wisnivesky JP, Lurslurchachai L, et al. Barriers to adherence to COPD guidelines among primary care providers. Respir Med. 2012 Mar;106(3):374–381.
- Gunen H, Yilmaz M, Aktas O, et al. for the ALPHABET study investigators. Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study. Int J Chron Obstruct Pulmon Dis. 2015;10:2485–2494.